NYSE:CO Global Cord Blood (CO) Stock Price, News & Analysis → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free CO Stock Alerts $1.35 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$1.35▼$1.3550-Day Range$1.20▼$2.0052-Week Range$2.03▼$5.50Volume402 shsAverage Volume216,519 shsMarket Capitalization$164.09 millionP/E Ratio2.11Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Get Global Cord Blood alerts: Email Address Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> About Global Cord Blood Stock (NYSE:CO)Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Read More CO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CO Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comGlobal Cord Blood (NYSE:CO) Coverage Initiated at StockNews.comMarch 20, 2024 | finance.yahoo.comBiobanking Market Outlook Forecast 2024-2029 - Virtual Biobanks Are Gaining PopularityMarch 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 19, 2024 | americanbankingnews.comGlobal Cord Blood (NYSE:CO) Research Coverage Started at StockNews.comMarch 18, 2024 | msn.comLondon-bound flight from Bangkok makes emergency landing after passenger's suspected suicide attemptMarch 18, 2024 | finance.yahoo.comCell Cryopreservation Market Forecast 2024-2029: Europe Set to Command Significant Share Amid Increasing Scientific AdvancementsMarch 15, 2024 | msn.comHow Safe Are Covid Vaccines? Here’s What We Know NowMarch 15, 2024 | msn.comICSE Class 10 Biology Question Paper 2023 Solved PDF, Check Important Questions and Answers for Last Minute RevisionMarch 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 14, 2024 | msn.com'Victorian' disease which killed millions now at worldwide high again - these are the symptomsMarch 13, 2024 | businesswire.comSangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPsMarch 13, 2024 | finance.yahoo.comFetal Monitoring Market revenue to reach USD 15.81 Billion by 2035, says Research NesterMarch 11, 2024 | markets.businessinsider.comBrain Canada Celebrates Brain Health Awareness Month with Boost your Brain Awareness CampaignMarch 9, 2024 | mirror.co.ukDesperate families lives are saved by strangers they've never met - delighted mums speak outFebruary 28, 2024 | msn.com'I wouldn’t be here without it': Baby's umbilical cord donation saved Emma's lifeFebruary 28, 2024 | finance.yahoo.comGlobal Biobanking Market Report 2024: Market Set to Surpass $75 Billion in 2024, Growing Demand for Umbilical Cord Blood BankingFebruary 28, 2024 | bbc.comToddler's mum calls stem cell donors 'superheroes'February 25, 2024 | apnews.comThe Red Cross did not ban people with COVID-19 vaccinations from donating bloodFebruary 23, 2024 | msn.comCovid vaccine side-effects: Rare risk of inflammation and swelling in brain and spinal cord discoveredFebruary 23, 2024 | msn.comAll about two rare Covid-19 vaccine side effects detected in a studyFebruary 23, 2024 | msn.comRecent Study Reveals Two New Side Effects of COVID-19 VaccinesFebruary 22, 2024 | theguardian.comTwo very rare Covid vaccine side-effects detected in global study of 99 millionFebruary 21, 2024 | msn.comWGA Awards: ‘Air,’ ‘Barbie,’ ‘Oppenheimer,’ ‘May December’ Among Film Screenplay NomineesFebruary 21, 2024 | yahoo.comHow John Singer Sargent still inspires fashion to this dayFebruary 20, 2024 | msn.comBiggest Covid vaccine study yet reveals links between shots and these conditionsFebruary 20, 2024 | msn.comCOVID vaccines linked to slight increases in heart, brain, blood disorders: studyFebruary 20, 2024 | msn.comCOVID vaccines linked to slight increases in heart, brain, blood disordersSee More Headlines Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/26/2018Today3/28/2024Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:CO CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone(523) 605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio2.11 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.24 billion Price / Sales0.13 Cash Flow$0.32 per share Price / Cash Flow4.19 Book Value$6.34 per share Price / Book0.21Miscellaneous Outstanding Shares121,551,000Free FloatN/AMarket Cap$164.09 million OptionableNo Data Beta0.16 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesTing ZhengChairman & Chief Executive OfficerBing Chuen ChenChief Financial Officer & DirectorXin XuChief Technology OfficerRui ArashiyamaCEO-Guangdong & Zhejiang DivisionsKey CompetitorsViemed HealthcareNASDAQ:VMD10X Capital Venture Acquisition Corp. IIINYSE:VCXBTelomir PharmaceuticalsNASDAQ:TELONektar TherapeuticsNASDAQ:NKTRAugmedixNASDAQ:AUGXView All Competitors CO Stock Analysis - Frequently Asked Questions How have CO shares performed in 2024? Global Cord Blood's stock was trading at $1.22 at the beginning of 2024. Since then, CO stock has increased by 10.7% and is now trading at $1.35. View the best growth stocks for 2024 here. How were Global Cord Blood's earnings last quarter? Global Cord Blood Co. (NYSE:CO) posted its quarterly earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by $0.09. The medical research company earned $37.14 million during the quarter. Is Global Cord Blood a good dividend stock? Global Cord Blood (NYSE:CO) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CO. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL). How do I buy shares of Global Cord Blood? Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CO) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.